{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:35:44Z","timestamp":1769128544061,"version":"3.49.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>There is an unmet need to investigate the lower airways in chronic obstructive pulmonary disease (COPD) to define pathogenesis and to identify potential markers to accelerate therapeutic development. Although bronchoscopy is well established to sample airways in various conditions, a comprehensive COPD research protocol has yet to be published.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the safety and tolerability of a comprehensive research bronchoscopy procedure suitable for multicenter trials and to identify factors associated with adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We report the detailed methodology used to conduct the bronchoscopy used in SPIROMICS (the Subpopulations and Intermediate Outcome Measures in COPD Study). The protocol entailed collection of tongue scrapings and oral rinses as well as bronchoscopy with airway inspection, bronchoalveolar lavage (BAL), protected brushings, and endobronchial biopsies. Visual airway characteristics were graded on a scale of 0 (normal appearance) to 3 (severe abnormality) in four domains: erythema, edema, secretions, and friability. Adverse events were defined as events requiring intervention. Logistic regression modeling assessed associations between adverse event occurrence and key variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We enrolled 215 participants. They were 61\u2009\u00b1\u20099 years old, 71% were white, 53% were male, and post-bronchodilator forced expiratory volume in 1 second was 89\u2009\u00b1\u200919% predicted. Self-reported asthma was present in 22% of bronchoscopy participants. Oral samples were obtained in greater than or equal to 99% of participants. Airway characteristics were recorded in 99% and were most often characterized as free of edema (61.9%). Less than 50% reported secretions, friability, or erythema. BAL yielded 111\u2009\u00b1\u200957 ml (50%) of the 223\u2009\u00b1\u200965 ml of infusate, brushes were completed in 98%, and endobronchial biopsies were performed in 82% of procedures. Adverse events requiring intervention occurred in 14 (6.7%) of 208 bronchoscopies. In logistic regression models, female sex (risk ratio [RR], 1.10; 95% confidence interval [CI], 1.02\u20131.19), self-reported asthma (RR, 1.17; 95% CI, 1.02\u20131.34), bronchodilator reversibility (RR, 1.17; 95% CI, 1.04\u20131.32), COPD (RR, 1.10; 95% CI, 1.02\u20131.20), forced expiratory volume in 1 second (RR, 0.97; 95% CI, 0.95\u20130.99), and secretions (RR, 1.85; 1.08\u20133.16) or friability (RR, 1.64; 95% CI, 1.04\u20132.57) observed during bronchoscopy were associated with adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A research bronchoscopy procedure that includes oral sampling, BAL, endobronchial biopsy, and brushing can be safely performed. Airway characteristics during bronchoscopy, demographics, asthma or COPD, and lung function may convey increased risk for procedure-related events necessitating intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201807-441oc","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T18:43:58Z","timestamp":1547750638000},"page":"439-446","source":"Crossref","is-referenced-by-count":26,"title":["Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease. Results from the SPIROMICS Bronchoscopy Substudy"],"prefix":"10.1093","volume":"16","author":[{"given":"J. Michael","family":"Wells","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, and"},{"name":"UAB Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Birmingham VA Medical Center, Birmingham, Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas A.","family":"Arenberg","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Barjaktarevic","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of California, Los Angeles, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surya P.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, and"},{"name":"UAB Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell P.","family":"Bowler","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, Colorado"},{"name":"University of Colorado at Denver, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A.","family":"Christenson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Couper","sequence":"additional","affiliation":[{"name":"Marsico Lung Institute, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T.","family":"Dransfield","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, and"},{"name":"UAB Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Birmingham VA Medical Center, Birmingham, Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MeiLan K.","family":"Han","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Iowa, Iowa City, Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Kaner","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Genetic Medicine, Weill Cornell Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Kleerup","sequence":"additional","affiliation":[{"name":"Wake Forest University, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando J.","family":"Martinez","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Genetic Medicine, Weill Cornell Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy C.","family":"Moore","sequence":"additional","affiliation":[{"name":"Wake Forest University, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2876-0258","authenticated-orcid":false,"given":"Sarah L.","family":"O\u2019Beirne","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Genetic Medicine, Weill Cornell Medicine, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Robert","family":"Paine","sequence":"additional","affiliation":[{"name":"Division of Respiratory, Critical Care, and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, Utah"},{"name":"Salt Lake City VA Medical Center, Salt Lake City, Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirupama","family":"Putcha","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev M.","family":"Raman","sequence":"additional","affiliation":[{"name":"Division of Respiratory, Critical Care, and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Graham","family":"Barr","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen I.","family":"Rennard","sequence":"additional","affiliation":[{"name":"IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom"},{"name":"Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Nebraska Medical Center, Omaha, Nebraska; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prescott G.","family":"Woodruff","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5191-4847","authenticated-orcid":false,"given":"Jeffrey L.","family":"Curtis","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan"},{"name":"VA Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"key":"2026012203371794900_bib1","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years\\ lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators","year":"2016","journal-title":"Lancet"},{"key":"2026012203371794900_bib2","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(18)30841-9","article-title":"Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study","volume":"391","author":"Wang","year":"2018","journal-title":"Lancet"},{"key":"2026012203371794900_bib3","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015 Mortality and Causes of Death Collaborators","year":"2016","journal-title":"Lancet"},{"key":"2026012203371794900_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaci.2011.02.042","article-title":"Safety of investigative bronchoscopy in the Severe Asthma Research Program","volume":"128","author":"Moore","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2026012203371794900_bib5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1164\/rccm.200407-966WS","article-title":"Investigative bronchoprovocation and bronchoscopy in airway diseases","volume":"172","author":"Busse","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203371794900_bib6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1164\/rccm.201210-1913OC","article-title":"Comparison of the respiratory microbiome in healthy nonsmokers and smokers","volume":"187","author":"Morris","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203371794900_bib7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1513\/AnnalsATS.201503-172OT","article-title":"Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study: sarcoidosis protocol","volume":"12","author":"Moller","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203371794900_bib8","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1513\/AnnalsATS.201503-143OC","article-title":"Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study: alpha-1 protocol","volume":"12","author":"Strange","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203371794900_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/thoraxjnl-2013-203897","article-title":"Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)","volume":"69","author":"Couper","year":"2014","journal-title":"Thorax"},{"key":"2026012203371794900_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12967-014-0374-z","article-title":"Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)","volume":"13","author":"Freeman","year":"2015","journal-title":"J Transl Med"},{"key":"2026012203371794900_bib11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.117.4.1055","article-title":"Serum lidocaine concentrations in asthmatics undergoing research bronchoscopy","volume":"117","author":"Langmack","year":"2000","journal-title":"Chest"},{"key":"2026012203371794900_bib12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/rmed.2000.0926","article-title":"Sedation in outpatient bronchoscopy","volume":"94","author":"Matot","year":"2000","journal-title":"Respir Med"},{"key":"2026012203371794900_bib13","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1164\/ajrccm\/140.6.1527","article-title":"Intraluminal airway inflammation in chronic bronchitis: characterization and correlation with clinical parameters","volume":"140","author":"Thompson","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"2026012203371794900_bib14","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1378\/chest.122.6.1909","article-title":"Safety of bronchoscopy, biopsy, and BAL in research patients with COPD","volume":"122","author":"Hattotuwa","year":"2002","journal-title":"Chest"},{"key":"2026012203371794900_bib15","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","article-title":"Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort","volume":"5","author":"Hastie","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026012203371794900_bib16","first-page":"337","article-title":"Immunological aspects of chronic non-infectious pulmonary diseases of the lower respiratory tract in man","volume":"1","author":"Hunninghake","year":"1981-1982","journal-title":"Clin Immunol Rev"},{"issue":"5","key":"2026012203371794900_bib17","doi-asserted-by":"crossref","first-page":"303S","DOI":"10.1378\/chest.117.5_suppl_1.303S-a","article-title":"Oxidants\/antioxidants and COPD","volume":"117","author":"MacNee","year":"2000","journal-title":"Chest"},{"key":"2026012203371794900_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00408-011-9284-5","article-title":"Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease","volume":"189","author":"Reynolds","year":"2011","journal-title":"Lung"},{"key":"2026012203371794900_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/thx.54.8.697","article-title":"Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung","volume":"54","author":"Meyer","year":"1999","journal-title":"Thorax"},{"key":"2026012203371794900_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1034\/j.1399-3003.1999.14b01.x","article-title":"Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL","volume":"14","author":"Haslam","year":"1999","journal-title":"Eur Respir J"},{"key":"2026012203371794900_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7326\/0003-4819-66-4-651","article-title":"Bronchopulmonary lavage in normal subjects and patients with obstructive lung disease","volume":"66","author":"Finley","year":"1967","journal-title":"Ann Intern Med"},{"key":"2026012203371794900_bib22","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.93.03080937","article-title":"Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Group on BAL","volume":"3","author":"European Society of Pneumology Task Group on BAL","year":"1990","journal-title":"Eur Respir J"},{"key":"2026012203371794900_bib23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1183\/09031936.00078812","article-title":"Application of \u2019omics technologies to biomarker discovery in inflammatory lung diseases","volume":"42","author":"Wheelock","year":"2013","journal-title":"Eur Respir J"},{"key":"2026012203371794900_bib24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.201408-1458OC","article-title":"Asthma\u2013COPD overlap: clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease","volume":"191","author":"Christenson","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203371794900_bib25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1701632","article-title":"Airway mucin concentration as a marker of chronic bronchitis","volume":"377","author":"Kesimer","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012203371794900_bib26","doi-asserted-by":"crossref","first-page":"3463104","DOI":"10.1155\/2016\/3463104","article-title":"The role of interleukin-23 in the early development of emphysema in HIV1+ smokers","volume":"2016","author":"Barjaktarevic","year":"2016","journal-title":"J Immunol Res"},{"key":"2026012203371794900_bib27","doi-asserted-by":"crossref","first-page":"e02287-16","DOI":"10.1128\/mBio.02287-16","article-title":"Bacterial topography of the healthy human lower respiratory tract","volume":"8","author":"Dickson","year":"2017","journal-title":"MBio"},{"key":"2026012203371794900_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaci.2017.07.039","article-title":"Alveolar eosinophilia in current smokers with chronic obstructive pulmonary disease in the SPIROMICS cohort","volume":"141","author":"Martinez","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026012203371794900_bib29","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/rccm.200202-150WS","article-title":"Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment","volume":"168","author":"Jeffery","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203371794900_bib30","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1164\/rccm.201601-0002OC","article-title":"Steroid-induced deficiency of mucosal-associated invariant T cells in the chronic obstructive pulmonary disease lung: implications for nontypeable Haemophilus influenzae infection","volume":"194","author":"Hinks","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203371794900_bib31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-2600(17)30207-2","article-title":"Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort","volume":"5","author":"Han","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026012203371794900_bib32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S2213-2600(13)70117-6","article-title":"Use of bronchoalveolar lavage to assess the respiratory microbiome: signal in the noise","volume":"1","author":"Twigg","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026012203371794900_bib33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.acra.2014.08.015","article-title":"Parametric response mapping monitors temporal changes on lung CT scans in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)","volume":"22","author":"Boes","year":"2015","journal-title":"Acad Radiol"},{"key":"2026012203371794900_bib34","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1164\/rccm.201506-1208PP","article-title":"SPIROMICS protocol for multicenter quantitative computed tomography to phenotype the lungs","volume":"194","author":"Sieren","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203371794900_bib35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1164\/rccm.201604-0871OC","article-title":"Age and small airway imaging abnormalities in subjects with and without airflow obstruction in SPIROMICS","volume":"195","author":"Martinez","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203371794900_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1445-5994.2010.02261.x","article-title":"The safety of flexible fibre-optic bronchoscopy and proceduralist-administered sedation: a tertiary referral centre experience","volume":"42","author":"Dang","year":"2012","journal-title":"Intern Med J"},{"key":"2026012203371794900_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/LBR.0000000000000333","article-title":"Bronchoscopy safety in patients with chronic obstructive lung disease","volume":"24","author":"Bellinger","year":"2017","journal-title":"J Bronchology Interv Pulmonol"},{"key":"2026012203371794900_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/COPD.S119575","article-title":"Flexible bronchoscopy with moderate sedation in COPD: a case-control study","volume":"12","author":"Grendelmeier","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203371794900_bib39","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.athoracsur.2017.01.062","article-title":"Severe chronic obstructive pulmonary disease is not associated with complications after navigational bronchoscopy procedures","volume":"104","author":"Towe","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2026012203371794900_bib40","doi-asserted-by":"crossref","first-page":"e0116108","DOI":"10.1371\/journal.pone.0116108","article-title":"Chronic bronchitis and current smoking are associated with more goblet cells in moderate to severe COPD and smokers without airflow obstruction","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"2026012203371794900_bib41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1183\/09031936.04.00063003","article-title":"Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma","volume":"24","author":"Elston","year":"2004","journal-title":"Eur Respir J"},{"key":"2026012203371794900_bib42","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jcrc.2014.06.006","article-title":"Safety of research bronchoscopy in critically ill patients","volume":"29","author":"Prebil","year":"2014","journal-title":"J Crit Care"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/16\/4\/439\/66399496\/annalsats_16_4_439.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/16\/4\/439\/66399496\/annalsats_16_4_439.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:41:02Z","timestamp":1769071262000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/16\/4\/439\/8424803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,1]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201807-441oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2019,4,1]]}}}